SINO BIOPHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 1177 for the last semiannual is 17.20 B HKD, and it's 45.78% higher compared to the previous semiannual. The net income of H1 24 is 1.56 B HKD.